Biopharma Service Providers Address a Full Plate of Challenges

Publication
Article
BioPharm InternationalBioPharm International-06-15-2016
Volume 2016 ebook
Issue 1
Pages: 4–9

Contract service providers debate the pros and cons of consolidation, accelerated drug approvals, regulatory issues, and the impact of new therapies.

Contract service providers debate the pros and cons of consolidation, accelerated drug approvals, regulatory issues, and the impact of new therapies.

Participants in this discussion included: Don Paul Kovarcik, technical marketing specialist, Ajinomoto Althea; Robert H. DeWit, president of MPI Research; John Allinson, head of biomarker strategy, drug development services at LGC; Michael Lehmann, president, global sales and marketing, Patheon; Brian Hampson, vice-president, global manufacturing sciences and technology, PCT, a Caladrius Company; Fiona Greer, global director, BioPharma Services Development–Life Sciences, SGS; and Peter Soelk, managing director, Vetter Pharma International.

Download the

BioPharm International 2016 Outsourcing Resources eBook

.

 

Articles in this issue
BPsupp0616_RT_manufacturing_185.jpg
Contract Service Providers Gear Up to Develop Emerging Therapies
BPsupp0616_RT_business_185.jpg
Biopharma Service Providers Address a Full Plate of Challenges
BPsupp0616_SupplyChain_Vetter_185.jpg
Dealing with Pharmaceutical Supply-Chain Complexities
BPsupp0616_3MDrugDelivery_185.jpg
Keeping it Simple: Collaborating for Success in Drug Delivery
BPsupp0616_china_185.jpg
Regulatory Reform in China: Implications for Global Biopharmaceutical Companies
BPsupp0616_Langer_185.jpg
Biomanufacturers Demand Higher Quality Standards in 2016
BPsupp0616_Parexel_185.jpg
Preventing Phase III Failures
BPsupp0616_CMO-News_185.jpg
Outsourcing Industry Marked by Considerable Investments in 2016
Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

AstraZeneca to Acquire EsoBiotec, Boosting Cell Therapy Portfolio

Patrick Lavery
March 21st 2025
Article

EsoBiotec’s proprietary lentiviral platform primarily enables the immune system to attack cancers but could ultimately offer patients cell therapy treatments delivered in minutes rather than several weeks.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Avantor Presents Completed Hydration Expansion at DCAT Week 2025

Susan Haigney
March 18th 2025
Article

The company gave a first look at its completed expansion at its manufacturing site in Gliwice, Poland during DCAT Week 2025 in New York City.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Shilpa Biologicals Partners with mAbTree Biologics to Develop and Commercialize a Novel Immuno-Oncology Asset

Feliza Mirasol
March 17th 2025
Article

Under the agreement, Shilpa will undertake development and commercial supply for a novel checkpoint inhibitor for immuno-oncology indications.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

DCAT Member Companies Present Latest News to Start DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

The Member Company Announcement Forum is the kickoff event of the annual DCAT Week in New York City, which is being held from March 17–20.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

© 2025 MJH Life Sciences

All rights reserved.